Abvc Biopharma Inc (ABVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,088 | -12,036 | -5,135 | -3,248 | -1,195 |
| Depreciation Amortization | 5 | 12 | 9 | 6 | 3 |
| Income taxes - deferred | -87 | 824 | -187 | -111 | -51 |
| Accounts receivable | -1 | -121 | -172 | -137 | -239 |
| Accounts payable and accrued liabilities | N/A | -23 | -7 | -18 | -13 |
| Other Working Capital | -1,527 | -1,614 | -624 | -182 | -319 |
| Other Operating Activity | 4,702 | 5,360 | 1,042 | 834 | 400 |
| Operating Cash Flow | $-2,994 | $-7,598 | $-5,073 | $-2,857 | $-1,413 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -93 | -18 | -18 | N/A | N/A |
| Purchase Of Investment | N/A | -789 | -1,215 | -422 | -282 |
| Investing Cash Flow | $-93 | $-806 | $-1,233 | $-422 | $-282 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 4 | N/A | N/A | 5 |
| Debt Issued | N/A | 237 | 237 | 237 | -239 |
| Debt Repayment | N/A | -307 | -311 | -311 | 237 |
| Common Stock Issued | N/A | 11,120 | 6,875 | 0 | 40 |
| Other Financing Activity | 0 | -1,058 | -1,058 | 0 | 0 |
| Financing Cash Flow | $0 | $9,996 | $5,743 | $-75 | $42 |
| Exchange Rate Effect | -45 | -28 | 12 | 9 | -15 |
| Beginning Cash Position | 6,565 | 5,001 | 5,001 | 5,001 | 5,001 |
| End Cash Position | 3,433 | 6,565 | 4,450 | 1,657 | 3,333 |
| Net Cash Flow | $-3,133 | $1,564 | $-552 | $-3,344 | $-1,668 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,994 | -7,598 | -5,073 | -2,857 | -1,413 |
| Capital Expenditure | -93 | -18 | -18 | 0 | N/A |
| Free Cash Flow | -3,088 | -7,615 | -5,091 | -2,857 | -1,413 |